The pharmaceutical distribution sector operates within a uniquely challenging financial landscape. Distributors are often squeezed between paying suppliers within 30 days while waiting 60-90 days for payment from hospitals, pharmacies, and other healthcare providers. With global medicine spending projected to reach $1.9 trillion by 2027, the stakes are high, and cash flow gaps can severely limit a distributor's ability to stock inventory, secure new supplier contracts, or respond to market opportunities. For pharmaceutical distributors seeking a solution that offers immediate liquidity without compromising customer relationships or taking on credit risk, Resolve's B2B Net Terms platform provides a modern, non-recourse alternative to traditional factoring.
Resolve Pay provides pharmaceutical distributors with a truly modern alternative to factoring. Its platform offers up to 100% non-recourse financing, which means Resolve assumes the full credit risk of late payments or defaults from your customers. This is a game-changer for distributors dealing with a network of healthcare providers whose payment reliability can be a concern. The entire process is streamlined through an AI-powered platform that delivers instant credit decisions and funds approved invoices within 24 hours.
Pharmaceutical distributors who need to eliminate credit risk, protect their customer relationships, and get paid fast without the administrative burden of traditional factoring.
Resolve's model directly addresses the core challenge of pharmaceutical distribution: the cash flow gap created by extended payment terms. By advancing up to 100% of an invoice's value immediately and taking on the credit risk, Resolve allows distributors to confidently offer Net 30 or Net 60 terms to their buyers. This enhances their competitive position and boosts sales, all while protecting their cash flow. The white-labeled payment portal and collections process ensure that the distributor remains the primary point of contact for their customers, strengthening relationships rather than damaging them with third-party collection agencies.
With a client base of over 12,000 businesses, Resolve has deep expertise in the B2B space. Its AI-driven underwriting uses data far beyond traditional bureaus to make smarter, faster credit decisions, enabling distributors to get their customers approved quickly and efficiently.
The platform's comprehensive approach goes beyond simple invoice financing. Resolve provides end-to-end accounts receivable automation, from invoice generation to payment reminders and collections management. This streamlined workflow reduces the administrative burden on your team while ensuring that customers receive professional, consistent communication throughout the payment process. For distributors looking to scale their operations without proportionally scaling their AR staff, this automation is invaluable.
Resolve's non-recourse model is particularly valuable in the pharmaceutical distribution sector, where a single large healthcare provider default can significantly impact a distributor's financial stability. By transferring this risk to Resolve, distributors can pursue growth opportunities with confidence, knowing they're protected from customer credit events. The platform also enables distributors to extend credit to newer or smaller healthcare providers who might otherwise require cash-on-delivery terms, opening up new market segments without increasing risk exposure.
Resolve Pay's non-recourse financing model directly addresses the pharmaceutical distribution challenge by eliminating credit risk entirely—distributors receive up to 90-100% of invoice value within 24 hours while Resolve assumes responsibility for customer creditworthiness and collections.
eCapital brings nearly two decades of healthcare financing experience to the table, with a dedicated healthcare division that understands the specific needs of pharmaceutical clients. They offer both recourse and non-recourse factoring options, providing flexibility for distributors at different stages of growth or with different risk appetites. Their large funding capacity, with facilities up to $250 million, makes them suitable for mid-to-large pharmaceutical wholesalers.
Established pharmaceutical distributors with large receivables who need a factoring partner with healthcare sector expertise and substantial funding capacity.
eCapital's longevity in the healthcare space provides pharmaceutical distributors with a partner who understands the regulatory environment, the typical payment cycles, and the operational pressures unique to the sector. They have financed tens of thousands of clients and have documented experience creating facilities specifically for pharmaceutical clients. For a large distributor handling complex, high-value transactions, eCapital's ability to scale with growing businesses can be valuable.
altLINE, a division of The Southern Bank Company, offers the advantage of bank backing. This provides a level of financial stability, FDIC insurance, and regulatory compliance that can be particularly reassuring for pharmaceutical distributors operating in a highly regulated environment. Their factoring fees are competitive.
Pharmaceutical distributors who prioritize financial stability, regulatory compliance, and competitive factoring fees for high-value invoices.
The healthcare and pharmaceutical industries demand partners with strong financial foundations. altLINE's bank backing provides this assurance. The low starting rates can be beneficial for distributors handling high-value invoices, as even a small percentage difference can translate to significant savings. This stability and cost-effectiveness make it an option for distributors who want a traditional, reliable partner.
Factor Funding Co. has a dedicated pharmaceutical company factoring program and their team possesses specific expertise in FDA manufacturing standards and the unique regulatory environment of the sector. This specialization allows them to offer tailored solutions.
Pharmaceutical distributors who want a factoring partner that understands the pharmaceutical industry's regulatory compliance and specific payment cycle challenges.
For a distributor, working with a partner who understands the intricacies of the pharmaceutical supply chain can be advantageous. Factor Funding Co. provides industry-specific advice and solutions, which can be helpful for navigating complex situations or optimizing a financing strategy within the unique constraints of the pharma market.
Porter Capital is a family-owned factoring company with over 30 years of experience in the manufacturing and distribution sectors. This experience translates to an understanding of the capital-intensive nature of pharmaceutical production and distribution. They offer non-recourse factoring options and provide personalized, relationship-driven service.
Pharmaceutical distributors who value personalized service and a partner with decades of experience in the manufacturing and distribution space, with non-recourse protection available.
Pharmaceutical distribution shares many characteristics with general manufacturing and distribution, from inventory management to logistics. Porter Capital's history in these sectors means they understand the operational and financial pressures involved. Their experience allows them to be a knowledgeable partner for distributors.
Triumph Business Capital is a division of Triumph Financial, Inc. (NASDAQ: TFIN), a publicly traded company with a market cap of about $1.40 billion. This corporate backing provides financial stability, while their factoring model is built on flexibility, with no long-term contracts required.
Pharmaceutical distributors who want the financial backing of a large public company but the operational flexibility of a no-commitment, month-to-month factoring agreement.
For a distributor in a fluid market, the ability to scale factoring up or down without being locked into a long-term contract can be advantageous. Triumph provides this flexibility while also offering the security that comes from being part of a large, publicly accountable financial institution.
1st Commercial Credit offers competitive rates. Beyond basic invoice factoring, they also offer supply chain finance solutions, including purchase order financing, which can be useful for distributors who need to pay for inventory before their customer's invoice is even generated.
Pharmaceutical distributors with high invoice volumes who want competitive rates and may also need financing to cover the front end of their supply chain.
Distributors often face a cash crunch not just from slow-paying customers, but also from needing to pay suppliers upfront to secure inventory. The ability to get financing against a purchase order can solve this problem at its source, allowing a distributor to fulfill a large order without having the capital on hand. Combined with their competitive factoring rates for outstanding invoices, this makes them a comprehensive financial partner.
Universal Funding Corporation offers a competitive rate and high funding capacity, up to $20 million USD. They are known for their personalized approach, tailoring factoring programs to meet the specific needs of each client.
Large pharmaceutical distributors with high-value invoices who are seeking cost-effective financing solutions with a high ceiling on funding.
For a large-scale pharmaceutical wholesaler processing invoices worth hundreds of thousands of dollars, competitive rates combined with the ability to handle very large volumes make Universal Funding an option for major players in the distribution space.
Selecting the best financing partner for your pharmaceutical distribution business requires a careful assessment of your most pressing needs. The pharmaceutical distribution sector faces unique challenges that demand specialized solutions: extended payment cycles of 60-90 days, high-value transactions, regulatory complexity, and the constant need to maintain strong relationships with healthcare providers while managing cash flow constraints.
For distributors prioritizing credit risk elimination, non-recourse financing is essential. This feature transfers the risk of customer non-payment to the financing provider, protecting your business from the significant financial impact that a single healthcare provider default could cause. Resolve Pay's comprehensive non-recourse model exemplifies this approach, combining immediate funding with complete credit risk protection.
Cost-conscious distributors with established, reliable customer bases may prioritize the lowest possible fees to maximize margins on each transaction. In this case, comparing advance rates, funding speeds, and total cost of capital becomes critical. However, it's important to balance cost savings against the value of features like white-labeled customer experiences, automated AR workflows, and seamless ERP integrations that reduce administrative overhead.
Modern pharmaceutical distributors increasingly need more than basic factoring; they need a financing platform that automates workflows, protects relationships, and reduces risk. Resolve Pay represents this newer model by addressing common industry challenges such as long payment cycles, high-value orders, and the need to extend credit confidently. Its non-recourse structure gives distributors peace of mind by taking full responsibility for approved customer payments, making it easier to offer Net 30, Net 60, or Net 90 terms without absorbing default risk.
Another major advantage is Resolve’s AI-driven credit engine, which delivers approvals in seconds instead of days. That speed helps distributors respond faster in time-sensitive pharmaceutical supply situations and compete more effectively. By evaluating more signals than traditional credit bureaus, the platform can approve buyers who might otherwise be rejected, helping distributors enter new markets and expand their customer base. Just as important, the white-labeled payment experience keeps all customer interactions under your brand, preserving trust and professionalism.
Resolve also strengthens operations through seamless integrations and full AR automation. Its connections with QuickBooks Online, NetSuite, Shopify, BigCommerce, and Magento 2, plus flexible APIs, reduce manual work and improve visibility. Beyond funding, Resolve manages invoicing, reminders, and collections, enabling distributors to offer net terms and grow revenue while protecting margins, cash flow, and customer relationships.
Pharmaceutical distributors operate in a capital-intensive environment with a severe cash flow mismatch: they must pay their suppliers, often within 30 days, while waiting 60-90 days to get paid by their customers, which include hospitals, pharmacies, and other healthcare providers. This extended payment cycle creates a significant funding gap that can limit their ability to purchase inventory and grow their business.
Resolve is a modern, non-recourse alternative to factoring. While traditional factoring companies often notify your customer of the arrangement (which can damage relationships) and may offer recourse agreements (leaving you liable for bad debt), Resolve operates as a seamless extension of your brand. It takes on the full credit risk (non-recourse), provides a white-labeled payment portal for your customers, and integrates AI-powered automation to manage your entire AR workflow. You get paid fast, your customers enjoy flexible terms, and your relationships remain intact.
Yes, Resolve offers seamless integration with a wide range of financial tech stacks. It has built-in integrations with leading platforms including QuickBooks, Oracle, Shopify, BigCommerce, and Magento. Its flexible APIs also allow for custom integrations into virtually any existing system, ensuring that your transaction data is synced and reconciled automatically, saving your team significant time and reducing errors.
Yes, this is a core part of Resolve's offering. Resolve provides non-recourse financing, which means it assumes the credit assessment, credit decision, and the majority risk of late payments or defaults. If an approved customer fails to pay, Resolve, not you, bears the financial loss. This is a key differentiator from recourse factoring agreements, where the distributor remains liable.
Resolve's services are designed for established B2B businesses and require a minimum of $1 million USD in annual B2B revenue. This ensures that their platform and expertise are a good fit for businesses with a significant volume of B2B transactions and the corresponding need for sophisticated credit and cash flow management.
This post is to be used for informational purposes only and does not constitute formal legal, business, or tax advice. Each person should consult his or her own attorney, business advisor, or tax advisor with respect to matters referenced in this post. Resolve assumes no liability for actions taken in reliance upon the information contained herein.